Cash & equivalents decreased 39.9%
Cash & equivalents changed -39.9% from the comparable as-filed period.
$11.9B→$7.2B0 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →IBM financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory increased 39.6%
Inventory changed +39.6% from the comparable as-filed period.
$1.3B→$1.7B0 prior comparisons
Research & development increased 10.2%
Research & development changed +10.2% from the comparable as-filed period.
$2.1B→$2.3B0 prior comparisons
Stock-based compensation increased 12.9%
Stock-based compensation changed +12.9% from the comparable as-filed period.
$441.0M→$498.0M0 prior comparisons
Gross margin decreased by 1.04 points
Gross margin moved -1.04 percentage points from the comparable as-filed period.
58.77%→57.73%0 prior comparisons
Gross profit decreased 0.7%
Gross profit changed -0.7% from the comparable as-filed period.
$10.0B→$9.9B0 prior comparisons
Net income decreased 1.3%
Net income changed -1.3% from the comparable as-filed period.
$2.2B→$2.2B0 prior comparisons
Revenue increased 1.1%
Revenue changed +1.1% from the comparable as-filed period.
$17.0B→$17.2B0 prior comparisons
Selling, general & administrative decreased 0.9%
Selling, general & administrative changed -0.9% from the comparable as-filed period.
$5.0B→$5.0B0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.